鉴定与凝血相关的基因作为儿科败血症休克的潜在诊断生物标志物
Hong Li1, Lihua Zhang1, Yan Luo1
1Department of Pediatrics, Longyan First Hospital of Fujian Medical University, Longyan City, China.
Computer methods in biomechanics and biomedical engineering
|November 13, 2024
概括
研究人员确定了关键的与凝血相关的基因 (CRG),与儿科败血症休克有关. 这些基因与免疫细胞相关,为这种关键疾病提供了新的诊断和治疗策略.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 儿童的感染性休克是一种具有复杂病理生理学的危及生命的疾病.
- 凝血相关基因 (CRG) 参与疾病进展,但它们在儿科败血症休克中的特定作用需要进一步阐明.
- 了解分子机制对于开发有效的诊断和治疗干预措施至关重要.
研究的目的:
- 为了确定与儿科败血症休克相关的关键凝血相关基因 (CRG).
- 探索儿童感染性休克的潜在病原性机制.
- 识别潜在的治疗点,包括小分子化合物.
主要方法:
- 利用GEO数据库和现有的文献来识别枢纽基因.
- 在已识别的枢纽基因和免疫细胞群体之间进行了相关性分析.
- 构建了一个竞争的内源RNA (ceRNA) 网络,以调查潜在的致病途径.
- 对候选小分子化合物进行选,以确定已识别的途径为目标.
主要成果:
- 确定了五个枢纽基因,证明了儿科败血症休克的显著诊断性能.
- 建立了这些枢纽基因与各种免疫细胞类型之间的强烈相关性.
- 开发了一个ceRNA网络,揭示了潜在的分子机制.
- 确定了10个候选小分子化合物进行进一步研究.
结论:
- 已识别的枢纽基因在免疫反应和儿科败血症休克的疾病发展中发挥着重要作用.
- 这些发现为诊断和机制评估儿科败血症休克提供了新的见解.
- 已识别的基因和化合物代表了未来治疗策略的潜在目标.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
60
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
60


